Clinical Trial Update: Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a pre-filled insulin pen in Type 2 diabetes patients on twice-daily insulin reported complaints associated with its use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED